LUBNA SIDDIKI: Open Payments
NPI 1497700942 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 81 payments from 14 companies in 2025. Trend: 2023 $729 · 2024 $1,247 · 2025 $1,451
Food & beverage: $1,412Education: $39
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $217 |
| Otsuka America Pharmaceutical, Inc. | 12 | $211 |
| Alkermes, Inc. | 10 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $172 |
| Teva Pharmaceuticals USA, Inc. | 12 | $169 |
| E.R. Squibb & Sons, L.L.C. | 7 | $146 |
| Vanda Pharmaceuticals Inc. | 4 | $97 |
| Janssen Pharmaceuticals, Inc | 4 | $79 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Lundbeck LLC | 2 | $36 |
Products named: VRAYLAR, REXULTI, CAPLYTA, UZEDY, COBENFY, LYBALVI, FANAPT, SPRAVATO.
Industry payments across TX — which companies pay providers there.
